[go: up one dir, main page]

SE9002339L - Terapeutisk komposition och foerfarande foer dess framstaellning - Google Patents

Terapeutisk komposition och foerfarande foer dess framstaellning

Info

Publication number
SE9002339L
SE9002339L SE9002339A SE9002339A SE9002339L SE 9002339 L SE9002339 L SE 9002339L SE 9002339 A SE9002339 A SE 9002339A SE 9002339 A SE9002339 A SE 9002339A SE 9002339 L SE9002339 L SE 9002339L
Authority
SE
Sweden
Prior art keywords
active substance
pct
cover layer
matrix
colon
Prior art date
Application number
SE9002339A
Other languages
Unknown language ( )
English (en)
Other versions
SE9002339D0 (sv
Inventor
P Edman
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Priority to SE9002339A priority Critical patent/SE9002339L/sv
Publication of SE9002339D0 publication Critical patent/SE9002339D0/sv
Priority to ES91913139T priority patent/ES2094815T3/es
Priority to PCT/SE1991/000475 priority patent/WO1992000732A1/en
Priority to DK91913139.1T priority patent/DK0610178T3/da
Priority to DE69123159T priority patent/DE69123159T2/de
Priority to AT91913139T priority patent/ATE145132T1/de
Priority to JP91512398A priority patent/JPH05508156A/ja
Priority to AU82272/91A priority patent/AU8227291A/en
Priority to US07/958,369 priority patent/US5505966A/en
Priority to EP91913139A priority patent/EP0610178B1/en
Publication of SE9002339L publication Critical patent/SE9002339L/sv
Priority to GR960403526T priority patent/GR3022337T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE9002339A 1990-07-04 1990-07-04 Terapeutisk komposition och foerfarande foer dess framstaellning SE9002339L (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE9002339A SE9002339L (sv) 1990-07-04 1990-07-04 Terapeutisk komposition och foerfarande foer dess framstaellning
EP91913139A EP0610178B1 (en) 1990-07-04 1991-07-03 Therapeutical composition and process for its preparation
DE69123159T DE69123159T2 (de) 1990-07-04 1991-07-03 Therapeutische zusammensetzung und verfahren für ihre herstellung
PCT/SE1991/000475 WO1992000732A1 (en) 1990-07-04 1991-07-03 Therapeutical composition and process for its preparation
DK91913139.1T DK0610178T3 (da) 1990-07-04 1991-07-03 Terapeutisk præparat og fremgangsmåde til dets fremstilling
ES91913139T ES2094815T3 (es) 1990-07-04 1991-07-03 Composicion terapeutica y proceso para su preparacion.
AT91913139T ATE145132T1 (de) 1990-07-04 1991-07-03 Therapeutische zusammensetzung und verfahren für ihre herstellung
JP91512398A JPH05508156A (ja) 1990-07-04 1991-07-03 治療用組成物及びその製造方法
AU82272/91A AU8227291A (en) 1990-07-04 1991-07-03 Therapeutical composition and process for its preparation
US07/958,369 US5505966A (en) 1990-07-04 1991-07-03 Therapeutical composition and process for its preparation
GR960403526T GR3022337T3 (en) 1990-07-04 1997-01-22 Therapeutical composition and process for its preparation.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9002339A SE9002339L (sv) 1990-07-04 1990-07-04 Terapeutisk komposition och foerfarande foer dess framstaellning

Publications (2)

Publication Number Publication Date
SE9002339D0 SE9002339D0 (sv) 1990-07-04
SE9002339L true SE9002339L (sv) 1992-01-05

Family

ID=20379936

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9002339A SE9002339L (sv) 1990-07-04 1990-07-04 Terapeutisk komposition och foerfarande foer dess framstaellning

Country Status (11)

Country Link
US (1) US5505966A (sv)
EP (1) EP0610178B1 (sv)
JP (1) JPH05508156A (sv)
AT (1) ATE145132T1 (sv)
AU (1) AU8227291A (sv)
DE (1) DE69123159T2 (sv)
DK (1) DK0610178T3 (sv)
ES (1) ES2094815T3 (sv)
GR (1) GR3022337T3 (sv)
SE (1) SE9002339L (sv)
WO (1) WO1992000732A1 (sv)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK89592D0 (da) * 1992-07-07 1992-07-07 Helle Broendsted Laegemiddelafgivelsesindretning samt fremgangsmaade til fremstilling deraf
ES2068154B1 (es) * 1993-07-13 1995-11-16 Cantabria Ind Farmaceutica Sa Nuevas formulaciones analgesicas con amplio intervalo de accion.
ES2068762B1 (es) * 1993-07-21 1995-12-01 Lipotec Sa Un nuevo preparado farmaceutico para mejorar la biodisponibilidad de drogas de dificil absorcion y procedimiento para su obtencion.
DE4331539A1 (de) * 1993-09-17 1995-03-23 Basf Ag Dextranester, Verfahren zu ihrer Herstellung und ihre Verwendung zur Umhüllung oder Einbettung von Arzneimitteln
EP0730447B1 (en) * 1993-11-17 2002-02-20 Commonwealth Scientific And Industrial Research Organisation Fatty acid delivery system
US5849327A (en) * 1994-07-29 1998-12-15 Advanced Polymer Systems, Inc. Delivery of drugs to the lower gastrointestinal tract
US5656294A (en) * 1995-06-07 1997-08-12 Cibus Pharmaceutical, Inc. Colonic delivery of drugs
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
US6231888B1 (en) 1996-01-18 2001-05-15 Perio Products Ltd. Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
WO1997027843A2 (en) * 1996-01-30 1997-08-07 Advanced Polymer Systems, Inc. Targeted delivery of drugs to the lower gastrointestinal tract
US6764690B2 (en) * 1996-05-29 2004-07-20 Delsitech Oy Dissolvable oxides for biological applications
KR100219918B1 (ko) 1997-07-03 1999-09-01 김윤 대장선택적 약물전달용 조성물
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US7022683B1 (en) * 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
KR20000011247A (ko) * 1998-07-23 2000-02-25 김윤 다당류를이용한대장선택성약물전달조성물및약학제제
MXPA01007463A (es) 1999-01-29 2002-06-04 Losan Pharma Gmbh Composiciones farmaceuticas.
CN1285333C (zh) * 2000-06-07 2006-11-22 张昊 结肠定位释放的口服制剂及其制备方法
US6720005B1 (en) 2000-07-07 2004-04-13 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Coated, platform-generating tablet
EP1174127A1 (en) * 2000-07-21 2002-01-23 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Composition for targeted release of an actvie substance and process for producing such a composition
ATE377048T1 (de) * 2000-09-06 2007-11-15 Ap Pharma Inc Abbaubare polyacetal-polymere
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US6777000B2 (en) * 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
US6590059B2 (en) * 2001-05-11 2003-07-08 Ap Pharma, Inc. Bioerodible polyorthoesters from dioxolane-based diketene acetals
US20030152630A1 (en) * 2001-05-11 2003-08-14 Ng Steven Y. PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
US6524606B1 (en) * 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups
JP2005516020A (ja) * 2001-12-20 2005-06-02 ファルマシア・コーポレーション ゼロ次持続放出剤形およびその製造方法
FR2843302B1 (fr) 2002-08-09 2004-10-22 Centre Nat Rech Scient Forme galenique pour la delivrance colique de principes actifs
FR2843301B1 (fr) * 2002-08-09 2004-10-22 Centre Nat Rech Scient Forme galenique pour la delivrance colique de principes actifs
WO2004041244A2 (en) * 2002-10-30 2004-05-21 Pharmacia Corporation Oral extended release tablets and methods of making and using the same
US7737133B2 (en) 2003-09-03 2010-06-15 Agi Therapeutics Ltd. Formulations and methods of treating inflammatory bowel disease
US7825106B2 (en) * 2003-09-03 2010-11-02 Agi Therapeutics Ltd. Modified release formulations and methods of treating inflammatory bowel disease
US20070258879A1 (en) * 2005-12-13 2007-11-08 Philip Morris Usa Inc. Carbon beads with multimodal pore size distribution
US8273376B2 (en) 2006-11-17 2012-09-25 Da Volterra Colonic delivery of metallo-dependent enzymes
US20090269405A1 (en) * 2008-04-08 2009-10-29 Appian Labs, Llc Enzyme mediated delivery system
ZA200903858B (en) * 2008-06-19 2013-10-30 Univ Of Witwatesrand Johannesburg Pharmaceutical dosage form
CZ302789B6 (cs) * 2009-11-25 2011-11-09 Zentiva, K. S. Zpusob zvýšení rozpustnosti farmaceuticky aktivních látek a cílený (kontrolovaný) transport do streva
WO2017168426A1 (en) * 2016-03-30 2017-10-05 Vital Beverages Global Inc. Compositions and methods for selective gi tract delivery
WO2024178428A1 (en) * 2023-02-24 2024-08-29 Glanbia Nutritionals, Inc. Shelf stable organic nucleotide compositions and methods of manufacturing the same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959457A (en) * 1970-06-05 1976-05-25 Temple University Microparticulate material and method of making such material
US4024073A (en) * 1972-01-08 1977-05-17 Toray Industries, Inc. Hydrogel and production thereof
US3946110A (en) * 1974-05-30 1976-03-23 Peter, Strong Research And Development Company, Inc. Medicinal compositions and methods of preparing the same
US4042073A (en) * 1976-05-27 1977-08-16 Dana Corporation Disc brake mechanism actuating means
US4507327A (en) * 1983-05-23 1985-03-26 Q.P. Corporation Process for preparing edible products in the form of capsules
US4695463A (en) * 1985-05-24 1987-09-22 Warner-Lambert Company Delivery system for active ingredients and preparation thereof
SE459005B (sv) * 1985-07-12 1989-05-29 Aake Rikard Lindahl Saett att framstaella sfaeriska polymerpartiklar
DE3601132A1 (de) * 1986-01-16 1987-07-23 Christian Bannert Verfahren zur behandlung der schleimhaut
FR2608456B1 (fr) * 1986-12-18 1993-06-18 Mero Rousselot Satia Microcapsules a base de gelatine et de polysaccharides et leur procede d'obtention
US4915948A (en) * 1987-08-31 1990-04-10 Warner-Lambert Company Tablets having improved bioadhesion to mucous membranes
US4965252A (en) * 1988-06-28 1990-10-23 Hauser-Kuhrts, Inc. Cholesterol-lowering combination compositions of guar gum and niacin
EP0357793B1 (en) * 1988-03-09 1994-05-25 Snow Brand Milk Products Co., Ltd. Suspended-release preparation prepared by using alginates
FR2645439B1 (fr) * 1989-04-07 1991-06-21 Oreal Procede de preparation de capsules d'alginate(s) particulierement adaptees a un usage cosmetique, appareil pour sa mise en oeuvre et composition cosmetique contenant lesdites capsules

Also Published As

Publication number Publication date
GR3022337T3 (en) 1997-04-30
EP0610178A1 (en) 1994-08-17
WO1992000732A1 (en) 1992-01-23
DE69123159D1 (de) 1996-12-19
JPH05508156A (ja) 1993-11-18
SE9002339D0 (sv) 1990-07-04
DE69123159T2 (de) 1997-04-10
ATE145132T1 (de) 1996-11-15
EP0610178B1 (en) 1996-11-13
ES2094815T3 (es) 1997-02-01
DK0610178T3 (da) 1997-04-14
US5505966A (en) 1996-04-09
AU8227291A (en) 1992-02-04

Similar Documents

Publication Publication Date Title
SE9002339L (sv) Terapeutisk komposition och foerfarande foer dess framstaellning
DE69007623D1 (de) Arzneimittel mit verzögerter wirkstofffreigabe.
HK1031197A1 (en) Osmotic dosage form comprising first and second coats
DE68908456D1 (de) Matrix zur wirkstoffabgabe.
ATE226815T1 (de) Herstellung von arzneimitteln
EP0013606A3 (en) Polymeric diffusion matrix, method of its preparation and drug delivery device comprising said matrix
ATE349203T1 (de) Delavirdin tablettenformulierung
ATE156350T1 (de) Peptidarzneistoffe enthaltende pellets und ihre herstellung sowie deren verwendung
PT994887E (pt) Glicosidos modificados composicoes que compreendem os mesmos e metodos para a sua utilizacao
ATE85213T1 (de) Einen wirkstoff und ein in wasser quellendes polymer enthaltendes arzneimittel.
DE59607949D1 (de) Feste arzneimittelform mit polymerem material verteiltem wirkstoff
YU71293A (sh) Transdermalni terapijski sistem za davanje fizostigmina na koži i postupak za njegovu izradu
DE69416034D1 (de) Pharmazeutische Zubereitung zur rektalen Verabreichung von pharmakologisch wirksamen Verbindungen

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9002339-1

Effective date: 19940201

Format of ref document f/p: F